Search for: "SYNTHON IP V PFIZER"
Results 1 - 20
of 21
Sorted by Relevance
|
Sort by Date
29 Apr 2007, 7:07 pm
Synthon IP v. [read post]
1 Feb 2007, 2:04 pm
Synthon IP v. [read post]
2 Feb 2011, 3:52 am
: (Perhaps) only congress knows for sure (Patent Docs) US: More on data exclusivity (Patent Docs) US: BIO supports Patent Reform Act of 2011 (PatentlyBIOtech) US: President Obama proposes, BIO agrees (Patent Docs) US: Amicus briefs in AMP v USPTO: AARP (Patent Docs) US: Orphan drug designations and applications took off in 2010 while orphan drug approvals tapered off (FDA Law Blog) US: Dexcom wins major reexamination victories over Abbott (Reexamination Alert) Products Actonel (risedronate)… [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever… [read post]
27 May 2009, 5:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Pfizer acquires rights to 55 generic pills, 20 injectibles through new deals with Claris Lifesciences and Aurobindo (GenericsWeb) Sytrinol (Polymethoxylated flavones, tocotrienols) – US: District Court N D Illinois rules patent co-owned by US not immunised from infringement or validity determinations (Patent Docs) … [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing… [read post]
12 Apr 2011, 10:07 pm
Highlights this week included: Cosopt (Dorzolamide, Timolol) – UK: EWCA (Civ) rejects bid to revive patent covering Cosopt: Merck v Teva (IPKat) (The IP Factor) (EPLAW) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
28 Oct 2009, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) - US: District Court S D New York finds Teva infringed Alcon's patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) - US: District Court… [read post]
28 Oct 2009, 6:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) - US: District Court S D New York finds Teva infringed Alcon's patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine) - US: District Court… [read post]
28 Oct 2009, 7:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes amended Preserve Access to Affordable Generics Act (S.396) banning pay-for-delay settlements (Patent Baristas) Vigamox (Moxifloxacin) – US: District Court S D New York finds Teva infringed Alcon’s patent covering Vigamox (Patent Docs) (IP Factor) Alphagan (Brimonidine)… [read post]
7 Sep 2011, 4:22 am
: Pfizer v Teva (Property, intangible) [read post]
6 Apr 2011, 12:18 am
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
7 Jul 2008, 4:27 am
On June 17, the Federal Circuit affirmed the district court findings of inequitable conduct and exceptional case in Synthon IP v. [read post]
20 Jun 2008, 8:07 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Associated Press – AP files seven DMCA takedowns against Drudge Retort blog over users linking to its stories: (The Trademark Blog), (Techdirt), (Out-Law), (Electronic Frontier Foundation), (IPKat), (The Trademark Blog), ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK)… [read post]
29 Mar 2011, 9:19 pm
New pharmaceutical compulsory licenses proposed for patented medicines (Patentology) (ipwars) Canada: Election drum beats the life out of Access to Medicines Bill (IP Osgoode) EU opines on the patentability of human embryonic stem cells: Brüstle v Greenpeace (Kluwer Patent Blog) (IPBiz) EU: In the ECJ this week: Case C-195/09 Synthon v Merz Pharma and Case C-427/09 Generics (UK) v Synaptech (The SPC Blog) India: The production of generic drugs in… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property… [read post]
20 Jun 2008, 1:04 pm
"Synthon IP v. [read post]
